Beta-hydroxybutyrate (BHB), a ketogenic diet metabolite, enhances CAR T cell activation, offering a cost-effective boost for cancer immunotherapy.

Highlights: Keto diets improve CAR T cell function in cancer models Beta-hydroxybutyrate (BHB) is the key metabo

Highlights: Keto diets improve CAR T cell function in cancer models Beta-hydroxybutyrate (BHB) is the key metabo

A ketogenic diet supplement could improve CAR T cell function, offering a potential boost to cancer therapy, according to new research.

A basic dietary supplement in a ketogenic diet can enhance the function of 'CAR T' cells - a personalized treatment that reprograms patients' immune...

Ketogenic supplement shows promise as a new approach in cancer treatment, potentially aiding in tumor reduction and improving patient outcomes

Ketogenic supplement shows promise as a new approach in cancer treatment, potentially aiding in tumor reduction and improving patient outcomes

Opioids are often first-line treatments for cancer-related pain, but they can suppress the immune system and reduce the effectiveness of...

MONDAY, Dec. 16, 2024 -- Men who opt for "watchful waiting" instead of treatment for a low-risk prostate cancer might improve their odds if they take...

MONDAY, Dec. 9, 2024 -- Heat waves caused by climate change have been thought to pose the greatest risk to the world’s elderly, but a new study...